{"id":255874,"date":"2026-09-18T11:08:13","date_gmt":"2026-09-18T05:38:13","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=255874"},"modified":"2026-09-18T11:08:13","modified_gmt":"2026-09-18T05:38:13","slug":"ipca-laboratories-q2-results-fy27-preview-date-expectations","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/","title":{"rendered":"IPCA Laboratories Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter"},"content":{"rendered":"<p>Track the latest <a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\">IPCA Laboratories Ltd. share price<\/a> on Univest. The IPCA Laboratories Q2 results for the July to September 2026 quarter (Q2 FY27) are still pending, and this preview looks only at qualitative trends and confirmed historical numbers, since the IPCA Laboratories Q2 results for this quarter have not been announced yet.<\/p>\n<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;\"><em>Jun26 revenue Rs 2788 crore. Jun26 net profit Rs 424 crore. Sep25 (Q2 FY26) net profit Rs 281 crore. CMP Rs 1989.1. PE 36.72.<\/em><\/p>\n<p>This IPCA Laboratories Q2 results preview compares the last five reported quarters, Jun25 through Jun26, to lay out the base that the September 2026 quarter will be measured against. IPCA Laboratories operates in branded formulations, generics and API exports across domestic and regulated overseas markets, and that context matters when reading any historical numbers ahead of the IPCA Laboratories Q2 results.<\/p>\n<p style=\"margin-top:24px\"><a href=\"https:\/\/univest.in\/open-demat-account\">Open a free demat account on Univest and track IPCA Laboratories ahead of results season<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#IPCA_Laboratories_Q2_results_Date_When_Might_Q2_FY27_Be_Announced\" title=\"IPCA Laboratories Q2 results Date: When Might Q2 FY27 Be Announced\">IPCA Laboratories Q2 results Date: When Might Q2 FY27 Be Announced<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#IPCA_Laboratories_Q2_results_What_to_Expect_This_Quarter\" title=\"IPCA Laboratories Q2 results: What to Expect This Quarter\">IPCA Laboratories Q2 results: What to Expect This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Previous_Quarter_Performance_Before_the_IPCA_Laboratories_Q2_results_Q1_FY27_Jun_2026\" title=\"Previous Quarter Performance Before the IPCA Laboratories Q2 results: Q1 FY27 (Jun 2026)\">Previous Quarter Performance Before the IPCA Laboratories Q2 results: Q1 FY27 (Jun 2026)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Q2_FY26_Sep_2025_Base_Quarter_for_the_IPCA_Laboratories_Q2_results_Comparison\" title=\"Q2 FY26 (Sep 2025) Base Quarter for the IPCA Laboratories Q2 results Comparison\">Q2 FY26 (Sep 2025) Base Quarter for the IPCA Laboratories Q2 results Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Recent_Trend_Across_Five_Quarters_Ahead_of_the_IPCA_Laboratories_Q2_results\" title=\"Recent Trend Across Five Quarters Ahead of the IPCA Laboratories Q2 results\">Recent Trend Across Five Quarters Ahead of the IPCA Laboratories Q2 results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Key_Factors_to_Watch_Ahead_of_the_IPCA_Laboratories_Q2_results\" title=\"Key Factors to Watch Ahead of the IPCA Laboratories Q2 results\">Key Factors to Watch Ahead of the IPCA Laboratories Q2 results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Domestic_formulations_growth\" title=\"Domestic formulations growth\">Domestic formulations growth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#US_and_export_markets\" title=\"US and export markets\">US and export markets<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Operating_margin_sustainability\" title=\"Operating margin sustainability\">Operating margin sustainability<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Raw_material_costs\" title=\"Raw material costs\">Raw material costs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Regulatory_and_plant_compliance\" title=\"Regulatory and plant compliance\">Regulatory and plant compliance<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Valuation_Snapshot_Ahead_of_the_IPCA_Laboratories_Q2_results\" title=\"Valuation Snapshot Ahead of the IPCA Laboratories Q2 results\">Valuation Snapshot Ahead of the IPCA Laboratories Q2 results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#What_to_Watch_in_the_IPCA_Laboratories_Q2_results\" title=\"What to Watch in the IPCA Laboratories Q2 results\">What to Watch in the IPCA Laboratories Q2 results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#FAQs\" title=\"FAQs\">FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#When_will_the_IPCA_Laboratories_Q2_results_be_announced\" title=\"When will the IPCA Laboratories Q2 results be announced?\">When will the IPCA Laboratories Q2 results be announced?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#What_was_IPCA_Laboratoriess_net_profit_in_the_previous_quarter\" title=\"What was IPCA Laboratories&#8217;s net profit in the previous quarter?\">What was IPCA Laboratories&#8217;s net profit in the previous quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#What_was_IPCA_Laboratoriess_performance_in_Q2_FY26_the_base_quarter_for_comparison\" title=\"What was IPCA Laboratories&#8217;s performance in Q2 FY26, the base quarter for comparison?\">What was IPCA Laboratories&#8217;s performance in Q2 FY26, the base quarter for comparison?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/ipca-laboratories-q2-results-fy27-preview-date-expectations\/#Is_IPCA_Laboratories_a_pharma_company_that_reports_separate_export_numbers\" title=\"Is IPCA Laboratories a pharma company that reports separate export numbers?\">Is IPCA Laboratories a pharma company that reports separate export numbers?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"IPCA_Laboratories_Q2_results_Date_When_Might_Q2_FY27_Be_Announced\"><\/span>IPCA Laboratories Q2 results Date: When Might Q2 FY27 Be Announced<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No official Q2 FY27 results date has been announced yet, so any specific date for the IPCA Laboratories Q2 results would be speculation. Based on the historical pattern of how Indian NSE-listed companies typically report September quarter numbers, results are usually announced within four to six weeks of the quarter closing on 30 September. That places the likely window for the IPCA Laboratories Q2 results announcement somewhere between the last week of October 2026 and the middle of November 2026, broadly in line with when the Jun26 (Q1 FY27) numbers were reported a quarter earlier. Investors tracking the IPCA Laboratories Q2 results should watch official exchange filings on NSE and BSE for the confirmed board meeting date, rather than relying on an assumed schedule.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"IPCA_Laboratories_Q2_results_What_to_Expect_This_Quarter\"><\/span>IPCA Laboratories Q2 results: What to Expect This Quarter<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Since the September 2026 quarter has not closed and no numbers exist yet, expectations around the IPCA Laboratories Q2 results have to stay qualitative rather than a specific forecast figure. Broad themes investors are watching ahead of the IPCA Laboratories Q2 results include:<\/p>\n<ul>\n<li>continued momentum in the domestic branded formulations business, which has been the main driver of revenue growth in recent quarters<\/li>\n<li>the trajectory of API and export sales, particularly to the US and other regulated markets where regulatory approvals and pricing can swing margins<\/li>\n<li>whether the operating margin can hold near the high levels seen in Q1 FY27 or normalises closer to historical averages<\/li>\n<li>raw material and input cost trends, given the company operates across formulations and active pharmaceutical ingredients<\/li>\n<\/ul>\n<p>None of these qualitative points should be read as a projected revenue, profit or margin number for the IPCA Laboratories Q2 results, since that quarter has not been reported.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Previous_Quarter_Performance_Before_the_IPCA_Laboratories_Q2_results_Q1_FY27_Jun_2026\"><\/span>Previous Quarter Performance Before the IPCA Laboratories Q2 results: Q1 FY27 (Jun 2026)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/nandani-creation-q2-results-fy27-preview-date-expectations\">Nandani Creation Q2 Results FY27 Preview<\/a><\/p>\n<p>The quarter immediately preceding the IPCA Laboratories Q2 results was Q1 FY27, ended 30 June 2026. IPCA Laboratories reported revenue of Rs 2,788 crore, operating profit of Rs 670 crore at a margin of 24.03 percent, and net profit of Rs 424 crore in that quarter. This Jun26 print is the most recent actual, reported base that the IPCA Laboratories Q2 results will be measured sequentially against once announced.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q2_FY26_Sep_2025_Base_Quarter_for_the_IPCA_Laboratories_Q2_results_Comparison\"><\/span>Q2 FY26 (Sep 2025) Base Quarter for the IPCA Laboratories Q2 results Comparison<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The year ago quarter relevant to the IPCA Laboratories Q2 results is Q2 FY26, ended 30 September 2025. In that quarter IPCA Laboratories posted revenue of Rs 2,556 crore, operating profit of Rs 545 crore at a margin of 21.32 percent, and net profit of Rs 281 crore. This Sep25 print is the year on year base that the IPCA Laboratories Q2 results, once reported, will be compared against for growth calculations.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Recent_Trend_Across_Five_Quarters_Ahead_of_the_IPCA_Laboratories_Q2_results\"><\/span>Recent Trend Across Five Quarters Ahead of the IPCA Laboratories Q2 results<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Looking at all five reported quarters together gives a clearer picture than any single quarter before the IPCA Laboratories Q2 results. The table below lists revenue, operating profit, margin and net profit from Jun25 to Jun26.<\/p>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Revenue<\/th>\n<th>Operating Profit<\/th>\n<th>Margin<\/th>\n<th>Net Profit<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Q1 FY26 (Jun 2025)<\/td>\n<td>Rs 2,309 crore<\/td>\n<td>Rs 416 crore<\/td>\n<td>18.02%<\/td>\n<td>Rs 233 crore<\/td>\n<\/tr>\n<tr>\n<td>Q2 FY26 (Sep 2025)<\/td>\n<td>Rs 2,556 crore<\/td>\n<td>Rs 545 crore<\/td>\n<td>21.32%<\/td>\n<td>Rs 281 crore<\/td>\n<\/tr>\n<tr>\n<td>Q3 FY26 (Dec 2025)<\/td>\n<td>Rs 2,392 crore<\/td>\n<td>Rs 533 crore<\/td>\n<td>22.28%<\/td>\n<td>Rs 364 crore<\/td>\n<\/tr>\n<tr>\n<td>Q4 FY26 (Mar 2026)<\/td>\n<td>Rs 2,388 crore<\/td>\n<td>Rs 484 crore<\/td>\n<td>20.27%<\/td>\n<td>Rs 307 crore<\/td>\n<\/tr>\n<tr>\n<td>Q1 FY27 (Jun 2026)<\/td>\n<td>Rs 2,788 crore<\/td>\n<td>Rs 670 crore<\/td>\n<td>24.03%<\/td>\n<td>Rs 424 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>This five quarter trend is the historical backdrop investors will use to judge the IPCA Laboratories Q2 results once the September 2026 numbers are actually released, rather than any single quarter in isolation.<\/p>\n<p style=\"margin-top:24px\"><a href=\"https:\/\/univest.in\/open-demat-account\">Open a free demat account on Univest to follow IPCA Laboratories through the results season<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_to_Watch_Ahead_of_the_IPCA_Laboratories_Q2_results\"><\/span>Key Factors to Watch Ahead of the IPCA Laboratories Q2 results<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A handful of qualitative factors are likely to shape how the market reacts once the IPCA Laboratories Q2 results are finally announced.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Domestic_formulations_growth\"><\/span>Domestic formulations growth<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The domestic branded formulations business has been the single biggest swing factor for revenue and margin in the last few quarters, and its growth pace will matter a great deal for the IPCA Laboratories Q2 results.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"US_and_export_markets\"><\/span>US and export markets<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Export revenue, especially from the US generics pipeline and regulated markets, tends to be lumpy quarter to quarter, and any change here will influence the IPCA Laboratories Q2 results.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Operating_margin_sustainability\"><\/span>Operating margin sustainability<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Operating margin expanded sharply into Jun26, and whether that level is sustainable or partly one-off will be a key talking point around the IPCA Laboratories Q2 results.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/nacl-industries-q2-results-fy27-preview-date-expectations\">NACL Industries Q2 Results FY27 Preview<\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Raw_material_costs\"><\/span>Raw material costs<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Input cost movements for APIs and intermediates directly affect gross margin and will be watched closely as part of the IPCA Laboratories Q2 results.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Regulatory_and_plant_compliance\"><\/span>Regulatory and plant compliance<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any regulatory inspection outcome at manufacturing facilities can move sentiment well before the IPCA Laboratories Q2 results is even announced.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valuation_Snapshot_Ahead_of_the_IPCA_Laboratories_Q2_results\"><\/span>Valuation Snapshot Ahead of the IPCA Laboratories Q2 results<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At the current market price of Rs 1989.1, IPCA Laboratories trades at a price to earnings ratio of 36.72 and a price to book ratio of 6.26, based on a trailing EPS of Rs 54.17 and book value of Rs 318.0 per share. Return on equity stands at 15.7 percent and the debt to equity ratio is 0.1. The stock has a 52 week high of Rs 2014.0 and a 52 week low of Rs 1251.6, against a total market capitalisation of Rs 50,464 crore. Dividend yield is 0.31 percent. These are current, live valuation figures and not a forecast tied to the IPCA Laboratories Q2 results, but they form the backdrop against which the market will react once the IPCA Laboratories Q2 results are announced.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_to_Watch_in_the_IPCA_Laboratories_Q2_results\"><\/span>What to Watch in the IPCA Laboratories Q2 results<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Beyond the headline revenue and profit numbers, a few specific data points deserve attention once the IPCA Laboratories Q2 results are released:<\/p>\n<ul>\n<li>Commentary from management on demand trends in the domestic branded formulations segment<\/li>\n<li>Any update on US FDA or other regulatory inspections at key manufacturing sites<\/li>\n<li>Movement in operating margin compared to the Jun26 and Sep25 quarters<\/li>\n<li>Currency movements given the exposure to export markets<\/li>\n<\/ul>\n<p>Reading these alongside the headline numbers will give a fuller picture of the IPCA Laboratories Q2 results than the topline figures alone.<\/p>\n<p style=\"margin-top:24px\"><a href=\"https:\/\/univest.in\/open-demat-account\">Open a free demat account on Univest before the IPCA Laboratories results season<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The IPCA Laboratories Q2 results for the September 2026 quarter are not yet out, and this preview has deliberately stayed away from any specific revenue, profit or margin figure for that unreported quarter. What is clear from the reported Jun25 to Jun26 numbers is the trend line investors will use to judge the IPCA Laboratories Q2 results once the actual figures are announced. Investors tracking the IPCA Laboratories Q2 results should rely on the confirmed exchange filing for the results date and treat the qualitative factors discussed here as context, not a prediction.<\/p>\n<p style=\"border-left:4px solid #CC0000;background:#FFF5F5;padding:14px 18px;\"><strong>Disclaimer:<\/strong> Univest Securities Private Limited is a SEBI-registered Research Analyst (Registration No. INH000013776). This article is for educational and informational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Figures cited are historical, publicly disclosed quarterly financials and current market data; no specific Q2 FY27 results, estimates, or forecasts are implied. Please consult a SEBI-registered investment adviser and verify data independently before making any investment decision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><strong>FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_will_the_IPCA_Laboratories_Q2_results_be_announced\"><\/span>When will the IPCA Laboratories Q2 results be announced?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No official date has been announced yet. Based on the historical pattern of Indian NSE-listed companies, the IPCA Laboratories Q2 results are likely to be announced between late October 2026 and mid November 2026, roughly four to six weeks after the September quarter closes, but investors should confirm the exact date through exchange filings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_IPCA_Laboratoriess_net_profit_in_the_previous_quarter\"><\/span>What was IPCA Laboratories&#8217;s net profit in the previous quarter?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In Q1 FY27 (Jun 2026), the quarter right before the IPCA Laboratories Q2 results, IPCA Laboratories reported net profit of Rs 424 crore on revenue of Rs 2,788 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_IPCA_Laboratoriess_performance_in_Q2_FY26_the_base_quarter_for_comparison\"><\/span>What was IPCA Laboratories&#8217;s performance in Q2 FY26, the base quarter for comparison?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In Q2 FY26 (Sep 2025), the year ago base quarter relevant to the IPCA Laboratories Q2 results, IPCA Laboratories reported revenue of Rs 2,556 crore and net profit of Rs 281 crore, at a margin of 21.32 percent.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_IPCA_Laboratories_a_pharma_company_that_reports_separate_export_numbers\"><\/span>Is IPCA Laboratories a pharma company that reports separate export numbers?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, IPCA Laboratories reports both domestic formulations and export businesses including API and international generics, and both segments are tracked closely ahead of the IPCA Laboratories Q2 results.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"When will the IPCA Laboratories Q2 results be announced?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No official date has been announced yet. Based on the historical pattern of Indian NSE-listed companies, the IPCA Laboratories Q2 results are likely to be announced between late October 2026 and mid November 2026, roughly four to six weeks after the September quarter closes, but investors should confirm the exact date through exchange filings.\"}},{\"@type\":\"Question\",\"name\":\"What was IPCA Laboratories's net profit in the previous quarter?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"In Q1 FY27 (Jun 2026), the quarter right before the IPCA Laboratories Q2 results, IPCA Laboratories reported net profit of Rs 424 crore on revenue of Rs 2,788 crore.\"}},{\"@type\":\"Question\",\"name\":\"What was IPCA Laboratories's performance in Q2 FY26, the base quarter for comparison?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"In Q2 FY26 (Sep 2025), the year ago base quarter relevant to the IPCA Laboratories Q2 results, IPCA Laboratories reported revenue of Rs 2,556 crore and net profit of Rs 281 crore, at a margin of 21.32 percent.\"}},{\"@type\":\"Question\",\"name\":\"Is IPCA Laboratories a pharma company that reports separate export numbers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, IPCA Laboratories reports both domestic formulations and export businesses including API and international generics, and both segments are tracked closely ahead of the IPCA Laboratories Q2 results.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>A qualitative preview of the IPCA Laboratories Q2 results for the September 2026 quarter, covering the likely results date, the Jun26 and Sep25 comparison base, the five quarter trend and current valuation.<\/p>\n","protected":false},"author":29,"featured_media":255873,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[5805],"class_list":["post-255874","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results","tag-pharmaceuticals-sector"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["255873"],"rank_math_title":["IPCA Laboratories Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter"],"rank_math_description":["IPCA Laboratories Q2 results FY27 preview: likely results date, Jun26 vs Sep25 comparison, 5-quarter trend, key factors, valuation and what to watch this quarter."],"rank_math_focus_keyword":["IPCA Laboratories Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/ipca-laboratories-q2-results-fy27-preview-date-expectations.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/255874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=255874"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/255874\/revisions"}],"predecessor-version":[{"id":255875,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/255874\/revisions\/255875"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/255873"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=255874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=255874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=255874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}